SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0000950123-20-012434
Filing Date
2020-12-02
Accepted
2020-12-01 18:11:49
Documents
9

Document Format Files

Seq Description Document Type Size
1 F-3 lmnl-f3.htm F-3 608609
2 EX-5.1 lmnl-ex51_64.htm EX-5 36548
3 EX-23.1 lmnl-ex231_31.htm EX-23 7480
4 EX-23.2 lmnl-ex232_16.htm EX-23 3637
5 GRAPHIC gxgegsr0eynp000001.jpg GRAPHIC 4527
6 GRAPHIC gxgegsr0eynp000002.jpg GRAPHIC 4527
7 GRAPHIC gzs21s2ewu4d000001.jpg GRAPHIC 2008
8 GRAPHIC gzyxqnkgk3xd000001.jpg GRAPHIC 35627
9 GRAPHIC gzyxqnkgk3xd000002.jpg GRAPHIC 32328
  Complete submission text file 0000950123-20-012434.txt   766934
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 514-341-2115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-251065 | Film No.: 201361888
SIC: 2834 Pharmaceutical Preparations